Possible repurposing of pyrvinium pamoate for the treatment of mesothelioma: A pre‐clinical assessment

Author:

Barbarino Marcella12,Cesari Daniele1,Intruglio Riccardo1,Indovina Paola2,Namagerdi Asadoor1,Bertolino Franca Maria1,Bottaro Maria1,Rahmani Delaram1,Bellan Cristiana3,Giordano Antonio12

Affiliation:

1. Department of MedicineSurgery and NeuroscienceUniversity of SienaSienaItaly

2. Sbarro Institute for Cancer Research and Molecular MedicineCenter for BiotechnologyCollege of Science and TechnologyTemple UniversityPhiladelphiaPennsylvania

3. Department of Medical BiotechnologiesUniversity of SienaSienaItaly

Funder

Associazione Italiana per la Ricerca sul Cancro

Mesothelioma Applied Research Foundation

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Reference70 articles.

1. Global trends in mortality from malignant mesothelioma; analysis of WHO mortality database (1994–2013);Abdel‐Rahman O.;The Clinical Respiratory Journal,2018

2. Drug repurposing for the treatment of glioblastoma multiforme

3. WNT5A–ROR2 is induced by inflammatory mediators and is involved in the migration of human ovarian cancer cell line SKOV-3

4. Toxicity of nanoparticles and an overview of current experimental models;Bahadar H.;Iranian Biomedical Journal,2016

5. c-Met expression and MET amplification in malignant pleural mesothelioma

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3